Conformation-reconstructed multivalent antibody mimic for amplified mitigation of human islet amyloid polypeptide amyloidogenesis. Issue 7 (8th February 2022)

• Record Type: Journal Article
• Authors: Zhao, Liyuan; Wang, Sheng; Hu, Qigang; Jia, Haibo; Xin, Yanru; Luo, Liang; Meng, Fanling
• Is Part Of: Nanoscale. Volume 14:Issue 7(2022)
• Page Start: 2802
• Page End: 2815
• Publication Date: 2022-02-08
• Subjects: Nanoscience -- Periodicals; Nanotechnology -- Periodicals; 620.505
• DOI: 10.1039/d1nr08090c
• Languages: English
• ISSNs: 2040-3364

Abstract

Abstract : Conformation-reconstructed multivalent antibody mimic SPEPS@Au mitigates human islet amyloid polypeptide (IAPP) amyloidogenesis at low sub-stoichiometry in vitro and in vivo . Abstract : The misfolding and aggregation of human islet amyloid polypeptide (IAPP) into β-sheet-enriched amyloid fibrils is linked to type 2 diabetes. Antibodies are potent inhibitors of IAPP amyloidogenesis, but their preparation is usually complicated and expensive. Here we have created a multivalent antibody mimic SPEPS@Au through conformational engineering of the complementary-determining regions (CDRs) of antibodies on gold nanoparticles (AuNPs). By immobilizing both terminals of an IAPP-recognizing CDR loop (PEP) on the surface of AuNPs, the active conformation of PEP can simply recur on the gold-based antibody mimic, significantly enhancing the binding affinity between PEP and IAPP. SPEPS@Au mitigated amyloidogenesis of IAPP at low sub-stoichiometric concentrations, even after IAPP started aggregating, and dramatically reduced the amyloidogenesis-induced toxicity and ROS production both in vitro and in vivo . The conformation-reconstructed multivalent antibody mimic not only renders a facile strategy to approach potent amyloidogenesis inhibitors, but also provides new perspectives to exploit NP-based substitutes for antibodies in various applications.